NCT06540066 2026-03-16A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid TumorsBeOne MedicinesPhase 1 Terminated35 enrolled
NCT05935098 2026-03-13BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid TumorsBeOne MedicinesPhase 1 Terminated99 enrolled